Earnings Call · Q4 FY2024·2025-03-31

Q4 24EPS -2.64%·Rev n/aQ3 24EPS +22.54%·Rev n/aQ2 24EPS -34.85%·Rev n/aQ1 24EPS -16.67%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

MarDee Haring-Layton — Chief Financial Officer

Sabrina Martucci Johnson — President and Chief Executive Officer

+0.3%1d on move date+0.1% vs SPY3d+1.4%5d−0.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access